Safeguarding Australia's healthcare sector with a new nuclear medicine facility
ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.
Showing 81 - 100 of 1397 results
Bully T cells key to next generation flu vaccine
New cell-killing toxin discovered in an environmental pathogen
An international research team has discovered how a bacterial toxin, known as Ssp, is capable of entering and killing a wide range of living cells, including human cells using the Australian Synchrotron.
ANSTO supports investigations into new area of COVID research
ANSTO’s National Deuteration Facility has been providing high-quality deuterated lipids used in the construction of cell membrane models to support research that improves our understanding of how the virus interacts with elements of the cell membrane, a relatively new area of investigation.
New round of IAEA Regional Cooperative Agreements projects announced
ANSTO is coordinating and facilitating a new cycle of Australian project proposals for the Regional Cooperative Agreement (RCA).
Australia’s OPAL multi-purpose reactor prepares for new milestone
Routine transport of spent nuclear fuel
New approach can improve monitoring of contaminants in groundwater
The outcome could have significant implications for better monitoring, management and remedial action of groundwater globally.
New Paper shows that Deuteration can improve Photovoltaic Devices
New flow chemistry capability to enhance NDF production capacity
Optus adopts new Worker Safety App designed by workm8
Collaboration locates elusive oxygen ions in new solid electrolyte
$12.5 million for new jobs from ANSTO’s Innovation Precinct
The NSW Government will invest $12.5 million to support the expansion of the Innovation Precinct at the Lucas Heights campus of the Australian Nuclear Science and Technology Organisation (ANSTO).
Building new knowledge of advanced materials in extreme environments
An international research collaboration between the University of New South Wales (UNSW), the Shanghai Institute of Applied Physics (SINAP) and ANSTO has provided insights into the performance of advanced material for use in the high-temperature environment of molten salt systems.
Analysis of fingermarks with synchrotron techniques provide new insights
A new study by researchers from Curtin University using the infrared (IR) and X-ray fluorescence microscopy (XFM) beamlines at the Australian Synchrotron has provided a better understanding of the chemical and elemental composition of latent fingermarks.
New approach to breast cancer detection using synchrotron radiation
Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.
Australia's home of nuclear medicine welcomes new Board Members
New underground lab to shed light on dark matter
Stage 1 of the Stawell Underground Physics Laboratory was officially opened today. It will be home to multi-disciplinary scientists from five research partners who help us understand dark matter.
New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.